Industry News (Joint Venture)

Cancer Diagnostics Agreements Signed

Published in Cancer Weekly, August 30th, 1999

Immunicon Corp., Hutingdon Valley, Pennsylvania, announced the signing of a Sponsored Research Agreement (SRA) and Exclusive Licensing Agreement (ELA) with The University of Texas Southwestern Medical Center at Dallas.

The focus of the agreements is research in the field of cell-based diagnostics for cancer detection, monitoring, and staging. The principal investigator is Jonathan W. Uhr, MD, professor of Microbiology and Internal Medicine.

The SRA is for a period of three years and provides monetary support and other consideration for research into applications and further development of Immunicon's rare-cell detection and analysis platform...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1999-08-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry